- Home
- CLIR vs INKT Comparison
CLIR vs INKT Comparison
Compare CLIR & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLIR
- INKT
- Stock Information
- Founded
- CLIR 2008
- INKT 2017
- Country
- CLIR United States
- INKT United States
- Employees
- CLIR N/A
- INKT N/A
- Industry
- CLIR Industrial Machinery/Components
- INKT Medicinal Chemicals and Botanical Products
- Sector
- CLIR Industrials
- INKT Health Care
- Exchange
- CLIR Nasdaq
- INKT Nasdaq
- Market Cap
- CLIR 27.9M
- INKT 28.8M
- IPO Year
- CLIR 2012
- INKT 2021
- Fundamental
- Price
- CLIR $0.53
- INKT $62.86
- Analyst Decision
- CLIR Strong Buy
- INKT Strong Buy
- Analyst Count
- CLIR 1
- INKT 2
- Target Price
- CLIR $2.00
- INKT $37.50
- AVG Volume (30 Days)
- CLIR 55.2K
- INKT 2.4M
- Earning Date
- CLIR 08-13-2025
- INKT 08-12-2025
- Dividend Yield
- CLIR N/A
- INKT N/A
- EPS Growth
- CLIR N/A
- INKT N/A
- EPS
- CLIR N/A
- INKT N/A
- Revenue
- CLIR $2,895,000.00
- INKT N/A
- Revenue This Year
- CLIR $27.61
- INKT N/A
- Revenue Next Year
- CLIR $116.19
- INKT N/A
- P/E Ratio
- CLIR N/A
- INKT N/A
- Revenue Growth
- CLIR 10.88
- INKT N/A
- 52 Week Low
- CLIR $0.46
- INKT $4.56
- 52 Week High
- CLIR $1.72
- INKT $76.00
- Technical
- Relative Strength Index (RSI)
- CLIR 38.87
- INKT 57.39
- Support Level
- CLIR $0.50
- INKT $6.80
- Resistance Level
- CLIR $0.60
- INKT $7.88
- Average True Range (ATR)
- CLIR 0.06
- INKT 0.40
- MACD
- CLIR -0.00
- INKT 0.02
- Stochastic Oscillator
- CLIR 26.77
- INKT 58.86
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.